abstract |
The present invention relates to new aryl-substituted oxazolidions with cytokine inhibitory activity, processes for their preparation and their use as medicaments, in particular for the treatment of effects caused by the tumor necrosis factor (TNF), such as. B. Atherosclerosis. |